Pharmaceutical Care on a Patient with Similar Linear IgA Bullous Dermatosis Caused by Vancomyci

OBJECTIVE To explore the pharmaceutical care of clinical pharmacist for patient with similar linear IgA bullous dermatosis caused by drug. METHODS By participating in an elderly patient drug therapy for similar linear IgA bullous dermatosis caused by Vancomycin, pharmacists provided reasonable recommendations according to disease conditions. Through drug adjustment, improving treatment, individualized pharmaceutical care was conducted, while special pharmaceutical cares were offered to the patient. RESULTS The patient's temperature was constantly controlled, blisters of varying sizes scattered in body and burning sensation had received effective treatment, the patient was discharged from hospital when the condition was improved and adverse drug reaction was sufficiently relieved. CONCLUSION Clinical pharmacist can improve the level of clinical rational drug use through the pharmaceutical care on an elderly patient with similar linear IgA bullous dermatosis caused by Vancomycin.